143 related articles for article (PubMed ID: 25493319)
21. Tannic acid, an inhibitor of poly(ADP-ribose) glycohydrolase, sensitizes ovarian carcinoma cells to cisplatin.
Sun Y; Zhang T; Wang B; Li H; Li P
Anticancer Drugs; 2012 Oct; 23(9):979-90. PubMed ID: 22785358
[TBL] [Abstract][Full Text] [Related]
22. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
[TBL] [Abstract][Full Text] [Related]
23. Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells.
Pu YS; Chen J; Huang CY; Guan JY; Lu SH; Hour TC
J Urol; 2001 Jun; 165(6 Pt 1):2082-5. PubMed ID: 11371932
[TBL] [Abstract][Full Text] [Related]
24. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.
Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P
J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the in vitro synergistic effect of 5-fluorouracil and cisplatin on cervical carcinoma cells.
Yim EK; Lee SB; Lee KH; Kim CJ; Park JS
Int J Gynecol Cancer; 2006; 16(3):1321-9. PubMed ID: 16803524
[TBL] [Abstract][Full Text] [Related]
26. Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells.
Mansour GH; El-Magd MA; Mahfouz DH; Abdelhamid IA; Mohamed MF; Ibrahim NS; Hady A Abdel Wahab A; Elzayat EM
Bioorg Chem; 2021 Nov; 116():105329. PubMed ID: 34544028
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
Hsin IL; Wang SC; Li JR; Ciou TC; Wu CH; Wu HM; Ko JL
Phytomedicine; 2016 Dec; 23(13):1566-1573. PubMed ID: 27823620
[TBL] [Abstract][Full Text] [Related]
28. Diazene JK-279: potential anticancer drug.
Osmak M; Bordukalo T; Jernej B; Kosmrlj J; Polanc S
Anticancer Drugs; 1999 Oct; 10(9):853-9. PubMed ID: 10587296
[TBL] [Abstract][Full Text] [Related]
29. Effect of bee venom on transforming growth factor-beta1-treated hepatocytes.
Park JH; Kim KH; Kim SJ; Lee WR; Lee KG; Park JH; Park KK
Int J Toxicol; 2010; 29(1):49-56. PubMed ID: 20075187
[TBL] [Abstract][Full Text] [Related]
30. The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells.
Ip SW; Liao SS; Lin SY; Lin JP; Yang JS; Lin ML; Chen GW; Lu HF; Lin MW; Han SM; Chung JG
In Vivo; 2008; 22(2):237-45. PubMed ID: 18468409
[TBL] [Abstract][Full Text] [Related]
31. Cytokine and inflammatory mediators are associated with cytotoxic, anti-inflammatory and apoptotic activity of honeybee venom.
Salama MA; Younis MA; Talaat RM
J Complement Integr Med; 2020 May; 18(1):75-86. PubMed ID: 32452823
[TBL] [Abstract][Full Text] [Related]
32. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells.
Beketić-Oresković L; Jaksić M; Oresković S; Osmak M
Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146
[TBL] [Abstract][Full Text] [Related]
33. Diazenes: modificators of tumor cell resistance to cisplatin.
Osmak M; Bordukalo T; Kosmrlj J; Kvajo M; Marijanović Z; Eljuga D; Polanc S
Neoplasma; 1999; 46(4):201-6. PubMed ID: 10613598
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of bleomycin lethality in HeLa and V79 cells by bee venom.
Orsolić N
Arh Hig Rada Toksikol; 2009 Sep; 60(3):317-26. PubMed ID: 19789161
[TBL] [Abstract][Full Text] [Related]
35. Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines.
Mayer F; Mueller S; Malenke E; Kuczyk M; Hartmann JT; Bokemeyer C
Invest New Drugs; 2005 Jun; 23(3):205-11. PubMed ID: 15868376
[TBL] [Abstract][Full Text] [Related]
36. The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin.
Osmak M; Eljuga D
Res Exp Med (Berl); 1993; 193(6):389-96. PubMed ID: 8122044
[TBL] [Abstract][Full Text] [Related]
37. Investigation the effects of bee venom and H-dental-derived mesenchymal stem cells on non-small cell lung cancer cells (A549).
Sengul F; Vatansev H; Ozturk B
Mol Biol Rep; 2023 Dec; 51(1):2. PubMed ID: 38057592
[TBL] [Abstract][Full Text] [Related]
38. Effects of the Medicago scutellata trypsin inhibitor (MsTI) on cisplatin-induced cytotoxicity in human breast and cervical cancer cells.
Lanza A; Tava A; Catalano M; Ragona L; Singuaroli I; Robustelli della Cuna FS; Robustelli della Cuna G
Anticancer Res; 2004; 24(1):227-33. PubMed ID: 15015601
[TBL] [Abstract][Full Text] [Related]
39. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
[TBL] [Abstract][Full Text] [Related]
40. Synergistic Cytotoxic Effect from Combination of Wedelolactone and Cisplatin in HeLa Cell Line: A Novel Finding.
Sarwar S; Yu JQ; Nadeem H; Huq F
Drug Des Devel Ther; 2020; 14():3841-3852. PubMed ID: 33061291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
